Related Experiment Video

Updated: Aug 12, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
08:27

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

New aspects of prevention and therapy of meningitis

S L Kaplan1

  • 1Department of Pediatrics, Baylor College of Medicine, Houston, Texas.

Infectious Disease Clinics of North America
|March 1, 1992
PubMed

Insights

Cefotaxime and ceftriaxone are recommended for pediatric bacterial meningitis. Research is needed for optimal antibiotic therapy against penicillin-resistant Streptococcus pneumoniae and the role of dexamethasone, especially with new vaccines.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Bacterial meningitis remains a significant pediatric concern.
  • Cefotaxime and ceftriaxone are current first-line empiric treatments.
  • Emerging antibiotic resistance and vaccination impact pathogen prevalence.

Purpose of the Study:

  • To evaluate optimal antibiotic strategies for pediatric bacterial meningitis.
  • To address treatment challenges posed by resistant Streptococcus pneumoniae.
  • To investigate the role of dexamethasone in conjunction with antibiotics.

Main Methods:

  • Review of current treatment guidelines and emerging resistance patterns.
  • Analysis of clinical data on meningitis treatment outcomes.
  • Consideration of the impact of Haemophilus influenzae type b vaccination.

Main Results:

  • Cefotaxime and ceftriaxone are effective but require further evaluation for resistant strains.
  • Penicillin resistance in Streptococcus pneumoniae necessitates alternative therapeutic approaches.
  • Dexamethasone's adjunctive role requires further critical study.

Conclusions:

  • Optimal antibiotic therapy for pediatric meningitis needs ongoing research, particularly for resistant pathogens.
  • Vaccination strategies will influence the epidemiology of meningitis.
  • Further investigation into dexamethasone's efficacy is crucial for improving treatment outcomes.

More Related Videos

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...